Diabetes and risk reduction

Treatment for type 2 diabetes is being revised with the advent of replacement hormones, such as glucagon-like peptide-1 (GLP-1). GLP-1 is a digestive hormone that is released during meals to give the person a sense of fullness, slows the absorption of food from the gut, and decreases liver release of glucose. This new form of diabetic treatment is encouraging with the incidence of type 2 diabetes increasing in recent times due to a rise in obesity and sedentary lifestyles. Other methods of treatment include pancreatic cell transplant, the insulin producing cells will be transferred to a diabetic person to achieve a cure. The greatest risk with developing diabetes at a younger age, particularly with type 2 diabetes, is that it is completely avoidable with exercise and a normal weight, and the dire complications occur at an earlier age. That is the threat of kidney or heart failure can occur at 20 years of age. Many people do not realise that they are suffering from type 2 diabetes as they experience symptoms of fatigue, lethargy, extreme thirst, frequent urination, susceptibility to infections and vision changes over a prolonged period of time.

Source: summary of medical news story as reported by Health Telegraph

Related Disease Topics:

• Type 2 diabetes
• Obesity
• Diabetes
• Kidney failure
• Heart failure

Related Symptom Topics:

• Fatigue
• Lethargy
• Extreme thirst
• Frequent urination
• Susceptibility to infections
• Vision changes

Article Source Details

About: Diabetes and risk reduction

Date: 28 June 2005

Source: Health Telegraph

Author: Christine Doyle

URL: http://www.telegraph.co.uk/health/main.jhtml?view=DETAILS&grid=P8&targetRule=10&xml=/health/2005/06/28/hdiab28.xml

Related Medical Topics

This summary article refers to the following medical categories:

• Cause of diabetes
• Cause of type 2 diabetes
• Cause of insulin insensitivity
• Cause of insulin resistance
• Cause of fatigue
• Cause of lethargy
• Cause of extreme thirst
• Cause of frequent urination
• Cause of susceptibility to infections
• Cause of vision changes
• Risk and diabetes
• Risk and type 2 diabetes
• Risk and insulin insensitivity
• Risk and insulin resistance
• Risk and coma
• Risk and obesity
• Risk and heart failure
• Risk and kidney failure
• Diagnosis
• Diagnosis and diabetes
• Diagnosis and type 2 diabetes
• Diagnosis and insulin insensitivity
• Diagnosis and insulin resistance
• Diagnosis and coma
• Diagnosis and obesity
• Diagnosis and heart failure
• Diagnosis and kidney failure
• Fatigue
• Lethargy
• Extreme thirst
• Diagnosis and frequent urination
• Diagnosis and susceptibility to infections
• Diagnosis and vision changes
• Diagnosis and diabetic complications
• Medication
• Medication and insulin
• Medication and hypoglycemic
• Medication and hypoglycemic drugs
• Medication and diabetes
• Medication and type I diabetes
• Medication and type II diabetes
• Medication and anti-diabetic drugs
• Medication and glucagons-like peptide
• Medication and pancreatic transplant
• Medication and research
• Research and diabetes
• Research and type 2 diabetes
• Research and glucagons-like peptide
• Research and hormones
• Research and pancreas

More News Topics

Search Specialists by State and City